XML 30 R5.htm IDEA: XBRL DOCUMENT v3.24.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - EUR (€)
Share capital
Premiums related to share capital
Net profit (loss)
Translation reserves
Reserves
Total
Balance at the beginning at Dec. 31, 2020 € 386,302 € 139,667,602 € (33,619,000)   € 4,777,000 € 111,211,000
Balance at the beginning (in shares) at Dec. 31, 2020 38,630,261          
Net loss for the period     (49,635,000)     (49,635,000)
Remeasurement of defined benefit plans           82,000
Other comprehensive income (loss)       € (164,000) 82,000 (82,000)
Total comprehensive loss     (49,635,000) (164,000) 82,000 (49,717,000)
Appropriation of net income (loss)     33,619,000   (33,619,000)  
Issue of ordinary shares € 22,000 25,404,000       25,426,000
Issue of ordinary shares (in shares) 2,214,190          
Vesting of bonus shares (in shares) 29,100          
Vesting of bonus shares € 0       0  
Share-based payment compensation expenses         2,089,000 2,089,000
BSA share warrants subscription premium         49,000 49,000
Treasury shares         (267,000) (267,000)
Other         75,000 75,000
Balance at the end (in shares) at Dec. 31, 2021 40,873,551          
Balance at the end at Dec. 31, 2021 € 408,735 165,071,565 (49,635,000) (164,000) (26,815,000) 88,866,000
Net loss for the period     (54,274,000)     (54,274,000)
Remeasurement of defined benefit plans           425,000
Other comprehensive income (loss)       (107,000) 425,000 318,000
Total comprehensive loss     (54,274,000) (107,000) 425,000 (53,955,000)
Appropriation of net income (loss)     49,635,000   (49,635,000)  
Issue of ordinary shares € 13,000 9,354,000       9,366,000
Issue of ordinary shares (in shares) 1,260,618          
Transaction costs   (539,000)       (539,000)
Share-based payment compensation expenses         2,218,000 2,218,000
Treasury shares         (479,000) (479,000)
Balance at the end (in shares) at Dec. 31, 2022 42,134,169          
Balance at the end at Dec. 31, 2022 € 421,341 173,885,665 (54,274,000) (271,000) (74,286,000) 45,476,000
Net loss for the period     (110,426,000)     (110,426,000)
Remeasurement of defined benefit plans         (97,000) (97,000)
Currency translation differences       867,000   867,000
Total comprehensive loss     (110,426,000) 867,000 (97,000) (109,657,000)
Appropriation of net income (loss)     54,274,000   (54,274,000)  
Issue of ordinary shares € 96,000 30,491,000       30,587,000
Issue of ordinary shares (in shares) 9,618,638          
Transaction costs   (2,511,000)       (2,511,000)
Vesting of bonus shares (in shares) 363,000          
Vesting of bonus shares € 4,000 (4,000)        
Share-based payment compensation expenses         3,969,000 3,969,000
BSA share warrants subscription premium         2,000 2,000
Treasury shares         134,000 134,000
Other         (33,000) € (33,000)
Balance at the end (in shares) at Dec. 31, 2023 52,115,807         52,115,807
Balance at the end at Dec. 31, 2023 € 521,158 € 201,862,263 € (110,426,000) € 596,000 € (124,584,000) € (32,032,000)